Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019 2019-09-30 06:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal 2019-09-30 05:00
Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China 2019-09-27 18:52
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019 2019-09-27 14:00
New Clarivate Analytics report shows the cost to bring a drug to market has decreased to under $2B for the first time in over five years 2019-09-26 21:00
Thermo Fisher Scientific Expands Clinical Trials Capabilities and Announces Collaboration with Frontier Biotechnologies Inc. 2019-09-26 14:00
OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent 2019-09-26 01:01
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA's approval of the oral formulation of Akynzeo(R) in China 2019-09-25 12:11
Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market 2019-09-24 23:28
Global Pharmaceutical Functional and Multifunctional Excipients Industry to Cross the $10 Billion Mark by 2023 2019-09-24 22:45
China Biologic Forms Special Committee to Review "Going Private" Proposal 2019-09-24 20:00
PolyU develops a new class of antibiotic candidates for fighting against superbugs 2019-09-24 17:46
I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Multiple Cancer Types 2019-09-23 19:00
CARsgen Announces Investigational CAR-T Therapy CT053 Granted PRIME Eligibility by the European Medicines Agency 2019-09-23 18:00
CPhI recruiting freelance pharmaceutical authors contributing to the global industry professionals 2019-09-23 17:56
New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care 2019-09-23 14:00
2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors 2019-09-22 14:22
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab 2019-09-22 13:39
2019 CSCO | CStone releases preliminary results from the Phase Ia trial of CS1003 in Chinese patients with advanced tumors 2019-09-21 00:26
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma 2019-09-20 20:34
1 306 307 308 309 310 401